Missouri House Bill HB2160

Missouri 2026 Regular Session

• Introduced: 1/7/26

Caption

Adds mifepristone to the list of Schedule IV controlled substances and establishes the offense of coerced criminal abortion by means of fraud

Impact

The enactment of HB2160 is likely to reshape regulations surrounding the prescription and administration of abortifacient medications in Missouri. By listing mifepristone as a controlled substance, it aims to regulate its distribution more closely, which may consequently limit access for patients. The bill establishes penalties for any coercion involved in administering abortion-inducing drugs without a woman's informed consent, which could lead to class B felony charges against offenders.

Summary

House Bill 2160 aims to repeal section 195.017 of the Revised Statutes of Missouri and introduce provisions concerning abortifacient drugs, particularly focusing on mifepristone. The bill categorizes mifepristone as a Schedule IV controlled substance under state law, reflecting the government's determination to regulate its use significantly. This classification comes with specific conditions regarding the potential for abuse and accepted medical use, aligning with federal categorization efforts for controlled substances.

Contention

Debate surrounding HB2160 centers primarily on the impact of stricter regulations on reproductive healthcare services. Supporters argue that the bill is a necessary measure to prevent fraudulent practices in abortion procedures, while critics express concern that it may hinder women's access to safe reproductive health options. The implications of classifying mifepristone as a controlled substance highlight ongoing tensions between varying views on reproductive rights and healthcare accessibility.